呼吸道感染定量分子诊断

Quantitative molecular diagnosis of respiratory tract infections

定量分子诊断技术对于引起呼吸道感染的主要病原体的检测有很大潜力,可以为临床感染性疾病的诊治提供重要的信息,其不受患者是否接受抗生素治疗的影响,能够明确呼吸道感染真正的病原菌,可用于判断疾病的预后、区分定植与感染以及评估抗感染治疗的效果。

Quantitative molecular diagnosis for the detection of key pathogenic microorganism causes of LRTI has the potential to provide a more sensitive decision-making tool, closer to the time-point of patient admission than current standard methods. A quantitative molecular test may be a useful tool for diagnostic and prognostic purposes, and for severity assessment. Quantitative molecular diagnosis also has the ability to differentiate colonization from infection.